Enzymes for Industrial Applications

Stephan Lütz, Novartis



"Enzymes haven become first choice for certain syntheses, e.g. of chiral alcohols or amines, and there are many other opportunities still out there." 


Wed 4 Feb 2015, 15:00:

Applications of biocatalysis in drug discovery

  • synthesis of chiral building blocks with isolated enzymes
  • expanding the enzyme toolbox for metabolite synthesis
  • biocatalysis for natural products



  • 2013: Habilitation (venia docendi) in biochemistry, Biozentrum, University of Basel
  • 2009: Group Leader and Manager for Bioreactions, Novartis Pharma AG, Basel
  • 2004: Ph.D. in chemistry, Institute of Biotechnology, Forschungszentrum Jülich
  • 2000: diploma in chemistry / technical chemistry, University of Bonn









Jetzt Mitglied werden